Orris

Erectile dysfunction

Reading File
Finding Sources
Searching PubMed

"erectile dysfunction"[MeSH Terms] AND treatment

Searching Images

erectile dysfunction pathophysiology vascular neurogenic mechanism diagram

This pathophysiology diagram illustrates the biochemical mechanism by which Cinnamomum osmophloeum hydrosol influences erectile function through multi-pathway enzymatic inhibition within endothelial and vascular smooth muscle cells (VSMCs). The flowchart highlights four primary inhibitory targets: AChE (acetylcholinesterase), which breaks down acetylcholine into acetate and choline; ARG2 (arginase 2), which competes for arginine to produce L-ornithine and urea; ACE (angiotensin-converting enzyme), which converts Angiotensin I to the vasoconstrictor Angiotensin II; and PDE5 (phosphodiesterase type 5), which degrades cGMP. The diagram depicts the positive signaling cascade where acetylcholine activates muscarinic receptors (mAChR), increasing calcium and calmodulin (CAM) to activate phosphorylated eNOS (eNOS-P). This results in nitric oxide (NO) production, which diffuses to VSMCs to stimulate soluble guanylate cyclase (sGC). The sGC converts GTP to cGMP, activating protein kinase G (PKG) and leading to smooth muscle relaxation and vasodilation. Two novel PDE5 inhibitor isomers (trans- and cis-phenyloxetan-3-ol) are shown with their respective IC50 values (4.37 µM and 3.40 µM), demonstrating their structural role in maintaining cGMP levels to treat erectile dysfunction.

This pathophysiology diagram illustrates the biochemical mechanism by which Cinnamomum osmophloeum hydrosol influences erectile function through multi-pathway enzymatic inhibition within endothelial and vascular smooth muscle cells (VSMCs). The flowchart highlights four primary inhibitory targets: AChE (acetylcholinesterase), which breaks down acetylcholine into acetate and choline; ARG2 (arginase 2), which competes for arginine to produce L-ornithine and urea; ACE (angiotensin-converting enzyme), which converts Angiotensin I to the vasoconstrictor Angiotensin II; and PDE5 (phosphodiesterase type 5), which degrades cGMP. The diagram depicts the positive signaling cascade where acetylcholine activates muscarinic receptors (mAChR), increasing calcium and calmodulin (CAM) to activate phosphorylated eNOS (eNOS-P). This results in nitric oxide (NO) production, which diffuses to VSMCs to stimulate soluble guanylate cyclase (sGC). The sGC converts GTP to cGMP, activating protein kinase G (PKG) and leading to smooth muscle relaxation and vasodilation. Two novel PDE5 inhibitor isomers (trans- and cis-phenyloxetan-3-ol) are shown with their respective IC50 values (4.37 µM and 3.40 µM), demonstrating their structural role in maintaining cGMP levels to treat erectile dysfunction.

This pathophysiology diagram illustrates the therapeutic mechanisms of Low-Intensity Extracorporeal Shock Wave Therapy (LI-ESWT) in the treatment of erectile dysfunction (ED). The central flowchart displays LI-ESWT as the primary intervention, targeting a node labeled 'Erectile dysfunction' marked with a male symbol. Downstream of this interaction, the diagram identifies four key regenerative processes stimulated by shockwave energy: 1) Release of neurotrophic factors (depicted by orange star-burst icons), 2) Activation of Schwann cells (represented by green ovoid cell icons), 3) Mobilization of stem/progenitor cells (illustrated as green undifferentiated cells), and 4) Angiogenesis and nerve fiber regeneration (visualized as red branching vascular and neural structures). The diagram summarizes the biological pathways by which LI-ESWT promotes tissue repair, neovascularization, and improved hemodynamics within the penile corpora cavernosa. It is designed as an educational overview of regenerative medicine and urological therapy for medical students and clinicians.

This pathophysiology diagram illustrates the therapeutic mechanisms of Low-Intensity Extracorporeal Shock Wave Therapy (LI-ESWT) in the treatment of erectile dysfunction (ED). The central flowchart displays LI-ESWT as the primary intervention, targeting a node labeled 'Erectile dysfunction' marked with a male symbol. Downstream of this interaction, the diagram identifies four key regenerative processes stimulated by shockwave energy: 1) Release of neurotrophic factors (depicted by orange star-burst icons), 2) Activation of Schwann cells (represented by green ovoid cell icons), 3) Mobilization of stem/progenitor cells (illustrated as green undifferentiated cells), and 4) Angiogenesis and nerve fiber regeneration (visualized as red branching vascular and neural structures). The diagram summarizes the biological pathways by which LI-ESWT promotes tissue repair, neovascularization, and improved hemodynamics within the penile corpora cavernosa. It is designed as an educational overview of regenerative medicine and urological therapy for medical students and clinicians.

A multi-panel pathophysiology diagram and algorithm illustrating the molecular mechanisms of exosome therapy for erectile dysfunction (ED). The left and central sections detail signaling pathways initiated by various stem-cell-derived exosomes (ADSCs, BMSCs, CCSMCs, HUDSCs, and ESCs) and cavernous pericytes. These cells influence molecular targets in three key cell types: corpora cavernosum smooth muscle cells (CCSMC), vascular endothelial cells, and cavernous nerve cells. Key molecular shifts include up-regulation of eNOS, nNOS, α-SMA, and neurofilaments, alongside down-regulation of iNOS, TGF-̢1/Smad, and caspase-3. The diagram maps these signaling cascades (involving miR-21-5p, PTEN, ERK, AKT, and NGF) to five physiological outcomes: reduction in fibrosis and apoptosis, and promotion of proliferation, angiogenesis, and nerve regeneration. The right panel depicts an animal model (rat) demonstrating four therapeutic delivery methods: intracavernous injection, smearing, tail vein (systemic) injection, and nerve injury in situ injection. This educational infographic summarizes how regenerative medicine targets the underlying vascular and neural pathology of ED.

A multi-panel pathophysiology diagram and algorithm illustrating the molecular mechanisms of exosome therapy for erectile dysfunction (ED). The left and central sections detail signaling pathways initiated by various stem-cell-derived exosomes (ADSCs, BMSCs, CCSMCs, HUDSCs, and ESCs) and cavernous pericytes. These cells influence molecular targets in three key cell types: corpora cavernosum smooth muscle cells (CCSMC), vascular endothelial cells, and cavernous nerve cells. Key molecular shifts include up-regulation of eNOS, nNOS, α-SMA, and neurofilaments, alongside down-regulation of iNOS, TGF-̢1/Smad, and caspase-3. The diagram maps these signaling cascades (involving miR-21-5p, PTEN, ERK, AKT, and NGF) to five physiological outcomes: reduction in fibrosis and apoptosis, and promotion of proliferation, angiogenesis, and nerve regeneration. The right panel depicts an animal model (rat) demonstrating four therapeutic delivery methods: intracavernous injection, smearing, tail vein (systemic) injection, and nerve injury in situ injection. This educational infographic summarizes how regenerative medicine targets the underlying vascular and neural pathology of ED.

This pathophysiology diagram illustrates a proposed mechanism for endothelial cell (EC) dysfunction in Chronic Thromboembolic Pulmonary Hypertension (CTEPH). The process originates with 'Thrombus formation,' showing pulmonary thromboemboli (neointimal lesions) atop the intima, media, and adventitia layers of the vascular wall. This creates a microenvironment influenced by the unresolved clot, which acts upon pulmonary artery ECs. The schematic depicts two primary pathways for EC transformation: 1) Transition into 'Mesenchymal like cells' (Endothelial-to-Mesenchymal Transition/EnMT), characterized by a spindle shape and red filaments representing α-smooth muscle actin, and 2) transformation into 'Dysregulated ECs,' identified by a decreased number of autophagosomes and mitochondria. Both pathways converge to result in 'EC dysfunction.' The drug Rapamycin is shown as an inhibitory agent blocking the pathway toward dysregulated ECs. A detailed legend identifies cellular components including myofibroblast-like cells, mitochondria (small blue ovals), and autophagosomes (double-membrane circular structures). This diagram serves as an educational summary of how chronic clots contribute to pulmonary vascular remodeling and metabolic cellular defects.

This pathophysiology diagram illustrates a proposed mechanism for endothelial cell (EC) dysfunction in Chronic Thromboembolic Pulmonary Hypertension (CTEPH). The process originates with 'Thrombus formation,' showing pulmonary thromboemboli (neointimal lesions) atop the intima, media, and adventitia layers of the vascular wall. This creates a microenvironment influenced by the unresolved clot, which acts upon pulmonary artery ECs. The schematic depicts two primary pathways for EC transformation: 1) Transition into 'Mesenchymal like cells' (Endothelial-to-Mesenchymal Transition/EnMT), characterized by a spindle shape and red filaments representing α-smooth muscle actin, and 2) transformation into 'Dysregulated ECs,' identified by a decreased number of autophagosomes and mitochondria. Both pathways converge to result in 'EC dysfunction.' The drug Rapamycin is shown as an inhibitory agent blocking the pathway toward dysregulated ECs. A detailed legend identifies cellular components including myofibroblast-like cells, mitochondria (small blue ovals), and autophagosomes (double-membrane circular structures). This diagram serves as an educational summary of how chronic clots contribute to pulmonary vascular remodeling and metabolic cellular defects.

Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Here is a comprehensive, textbook-sourced overview of erectile dysfunction:

Erectile Dysfunction (ED)

Definition

Erectile dysfunction is "the inability to attain and/or maintain penile erection sufficient for satisfactory sexual performance" (NIH Consensus Development Panel, 1993). The DSM-5 defines "erectile disorder" as ED accompanied by clinically significant distress not better accounted for by a nonsexual mental health disorder or the direct effects of a substance or medical condition. - Textbook of Family Medicine 9e

Epidemiology

  • 10-15% of all adult American men suffer from ED, with incidence rising steeply with age. - Goldman-Cecil Medicine
  • In a landmark study, 52% of men aged 40-70 experienced some degree of ED.
  • Prevalence by age: ~2% at ages 40-49; ~6% at 50-59; ~17% at 60-69; ~39% at age 70+. - Textbook of Family Medicine 9e
  • ED is especially prevalent in men with type 2 diabetes mellitus, after radical prostatectomy, and in men with lower urinary tract symptoms/BPH.
  • ED is associated with increased cardiovascular risk - men with ED often develop cardiac symptoms later, suggesting a shared pathophysiologic continuum.

Pathophysiology

Normal erection requires intact functioning of four systems: vascular, neurologic, endocrine, and psychological.
The NO-cGMP Pathway (core mechanism):
  1. Sexual stimulation activates parasympathetic (and non-adrenergic, non-cholinergic) neurons in the corpus cavernosum.
  2. These release nitric oxide (NO) from nerve endings and endothelial cells.
  3. NO activates guanylate cyclase, raising intracellular cyclic GMP (cGMP) in cavernosal smooth muscle.
  4. cGMP causes smooth muscle relaxation → vasodilation → rapid blood inflow into the corpora cavernosa.
  5. Engorgement compresses small emissary veins against the tunica albuginea → venous occlusion → sustained erection.
  6. Phosphodiesterase type 5 (PDE5) degrades cGMP, terminating erection. - Textbook of Family Medicine 9e; Medical Physiology
In ED, there is decreased NO production by endothelial cells, reduced non-adrenergic/noncholinergic nerve activity, impaired cavernosal smooth muscle relaxation, reduced sinusoidal filling, and/or failure of veno-occlusion. - Goldman-Cecil Medicine

Etiology and Classification

CategoryExamples
VasculogenicAtherosclerosis, hypertension, hyperlipidemia, DM, smoking (most common organic cause)
NeurogenicRadical prostatectomy, pelvic surgery/radiation, spinal cord injury, peripheral neuropathy, Parkinson's disease, MS
EndocrineHypogonadism (testosterone deficiency), hyperprolactinemia, hyper/hypothyroidism
PsychogenicDepression, anxiety, relationship conflict, performance anxiety (most common overall cause)
Drug-inducedSee table below - medications account for up to 25% of ED cases
Systemic illnessRenal failure, liver disease, metabolic syndrome
AgingEven with normal testosterone, endothelial dysfunction increases with age

Drugs Commonly Associated with ED (Goldman-Cecil Table 216-9):

  • Antidepressants: SSRIs, TCAs, MAOIs
  • Antihypertensives: beta-blockers, clonidine, verapamil
  • Cardiac drugs: amiodarone, digoxin
  • Diuretics: thiazides, spironolactone
  • H2-blockers: cimetidine, ranitidine
  • Hormonal agents: corticosteroids, antiandrogens, LHRH agonists, 5-alpha-reductase inhibitors (finasteride, dutasteride)
Key cardiovascular link: Men with ED share risk factors with cardiovascular disease (smoking, obesity, metabolic syndrome, hyperlipidemia, DM2). Men with mild ED should be assessed for cardiovascular disease when other risk factors are present. - Goldman-Cecil Medicine

Diagnosis

The workup is primarily clinical:
  1. History: detailed medical and sexual history (patient and partner); screen for psychosocial factors (depression, anxiety, substance use, libido, relationship issues). Use the Sexual Health Inventory for Men (SHIM) questionnaire.
  2. Physical exam: genitourinary, cardiovascular, endocrine, and neurologic systems; prostate examination.
  3. Labs: fasting glucose or HbA1c, lipid panel, urinalysis, renal function, morning serum testosterone. Prolactin, LH, and free testosterone if hypogonadism is suspected (do not measure routinely - hyperprolactinemia accounts for <2% of ED). - Textbook of Family Medicine 9e; Goldman-Cecil
  4. Special tests (rarely needed): penile duplex Doppler ultrasound (for vascular insufficiency or veno-occlusive disease), nocturnal penile tumescence, cavernosometry.

Treatment

Step 1: Address Underlying Causes

  • Lifestyle: weight loss (improves erectile function in obese men), exercise, smoking cessation, alcohol reduction. - Textbook of Family Medicine 9e
  • Optimize glycemic control in diabetes.
  • Review and adjust medications if a drug cause is suspected (weigh risks/benefits).
  • Psychosexual counseling for psychogenic ED (though evidence is limited).

Step 2: First-Line - PDE5 Inhibitors

PDE5 inhibitors are the drugs of first choice for most men. They block PDE5, preventing cGMP breakdown, thereby potentiating NO-mediated smooth muscle relaxation. They act only in the presence of sexual arousal. - Tietz Textbook of Laboratory Medicine; Goldman-Cecil
DrugUsual DoseOnsetDurationNotes
Sildenafil (Viagra)50 mg (25-100 mg)20-60 min~4-5 hrsTake on demand; food reduces absorption
Vardenafil (Levitra)5-20 mg25-60 min4-6 hrs-
Tadalafil (Cialis)10-20 mg on demand; 2.5-5 mg daily30-60 minup to 36 hrsDaily dosing option; also treats BPH/LUTS
Avanafil50-200 mg~15 min~6 hrsFastest onset
  • Effective in ~60% of men overall; lower response rates in DM, spinal cord injury, post-prostatectomy.
  • Contraindications: concurrent nitrate use (risk of severe hypotension from cGMP accumulation). Also caution with alpha-blockers (orthostatic hypotension). - Goldman-Cecil Medicine
  • Side effects: headache, flushing, nasal congestion, dyspepsia; sildenafil can cause transient "blue vision" (PDE6 inhibition in the retina). - Medical Physiology
Testosterone supplementation: If testosterone is <275 ng/dL plus symptoms of deficiency, testosterone gel can moderately improve sexual function (if no contraindications). Adding testosterone to sildenafil in partial responders does not provide additional benefit. - Goldman-Cecil Medicine

Step 3: Second-Line Therapies

  • Intracavernosal alprostadil (prostaglandin E1 injection) - highly effective, including post-prostatectomy
  • Intraurethral alprostadil (MUSE suppository, 125-1000 mcg) - less invasive than injection
  • Vacuum erection device - non-pharmacologic, effective in most men
  • Low-intensity extracorporeal shock wave therapy (LI-ESWT) - emerging regenerative approach; stimulates angiogenesis, nerve fiber regeneration, Schwann cell activation, and neurotrophic factor release (see diagram below)
LI-ESWT mechanism in ED

Step 4: Third-Line - Surgical

  • Penile prosthesis implantation (inflatable or malleable) - reserved for failed medical therapy; high patient satisfaction rates.

Special Considerations

Post-Prostatectomy ED

  • ED after radical prostatectomy depends on: age (<65 years), preoperative potency, and bilateral neurovascular bundle (NVB) preservation.
  • Recovery is gradual: ~38% potent at 3 months, 54% at 6 months, 73% at 12 months, 86% at 18 months (Walsh et al.). - Campbell Walsh Wein Urology
  • PDE5 inhibitors (on-demand dosing) aid recovery; early penile rehabilitation contributes to long-term recovery.

ED in Peyronie's Disease

  • Prevalence of ED in Peyronie's disease is 37-58%.
  • Penile arterial insufficiency in 36%, veno-occlusive disease in 59% of those with Peyronie's and ED. - Campbell Walsh Wein Urology

ED as a Cardiovascular Sentinel

  • ED often precedes the onset of overt cardiovascular symptoms, making it an opportunity for early cardiac risk stratification and intervention. - Textbook of Family Medicine 9e

Recent Evidence (2024-2026)

These recent publications do not fundamentally alter established first-line PDE5 inhibitor therapy, which remains the standard of care.
Sources: Goldman-Cecil Medicine International Edition; Textbook of Family Medicine 9e; Campbell Walsh Wein Urology 3-Volume Set; Medical Physiology (Boron & Boulpaep); Tietz Textbook of Laboratory Medicine 7e; Goodman & Gilman's Pharmacological Basis of Therapeutics.

Erection on masturbation relations with ED

Finding Sources
Searching PubMed

"erectile dysfunction" AND "masturbation" AND psychogenic

Searching the Web

erection during masturbation but not intercourse psychogenic vs organic erectile dysfunction clinical significance

Reading File
Reading File
Reading File
Excellent. I now have authoritative content from multiple sources. Here is the complete answer:

Erection During Masturbation vs. During Intercourse - The Psychogenic vs. Organic ED Distinction

The Core Clinical Principle

The ability to achieve a normal erection during masturbation (or upon waking), while failing to do so during partnered sex, is one of the most diagnostically important findings in evaluating ED. It is a strong pointer toward psychogenic ED rather than organic ED.
The reasoning is straightforward: masturbation-induced erections use the same vascular, neurological, and hormonal machinery as partnered erections. If the mechanism works in one context, the physical apparatus is fundamentally intact. What differs is the psychological/situational context. - Campbell Walsh Wein Urology; Kaplan & Sadock's Comprehensive Textbook of Psychiatry

Psychogenic vs. Organic ED: The Diagnostic Table

Campbell Walsh Urology (Table 69.4) lays this out directly:
FeaturePsychogenic EDOrganic ED
OnsetSuddenGradual
ProgressionComplete, immediate lossIncremental, progressive
PatternSituational (partner/context-dependent)Global (fails in all situations)
Waking/morning erectionsPresent and normalPoor or absent
Masturbation erectionsNormal or near-normalPoor or absent
Nocturnal erections (NPT)NormalAbnormal
LibidoUsually preservedMay be reduced (if hormonal)
Age groupMore common in younger menMore common in older men
Associated factorsAnxiety, depression, relationship stress, new partner, major life eventDiabetes, vascular disease, smoking, surgery, medication, neuropathy

Why Masturbation Erections Are Preserved in Psychogenic ED

During masturbation:
  • There is no performance pressure or fear of judgment
  • The man is in a familiar, controlled environment
  • There is no partner anxiety, fear of inadequacy, or expectation to perform
  • Arousal is purely self-generated, allowing the NO-cGMP pathway to function freely
During intercourse, performance anxiety and related psychological stressors activate the sympathetic nervous system, which:
  1. Raises noradrenaline levels in the corpus cavernosum
  2. Causes vasoconstriction and smooth muscle contraction - the opposite of what is needed for erection
  3. Suppresses the parasympathetic NO release that drives erection
  4. Creates a vicious cycle: failure → more anxiety → more sympathetic activation → more failure
This is why the NHS Lothian Clinical Guidelines list "good quality self-stimulated or waking erections" as a hallmark feature pointing toward psychogenic rather than organic ED.

The Role of Nocturnal Penile Tumescence (NPT)

Nocturnal erections (during REM sleep) are another key marker. They are involuntary and occur independently of psychology - the brain is essentially offline. A normal man has 3-6 erections per night, each lasting >30 minutes, with maximal rigidity >70%. - StatPearls / NCBI
  • Psychogenic ED: NPT is normal - erections during sleep are preserved
  • Organic ED: NPT is abnormal or absent
This is the same principle as masturbation erections. Kaplan & Sadock states explicitly: "If a man reports having good erections with masturbation or with partners other than his usual one... organic causes for his disorder can be considered negligible, and costly diagnostic procedures can be avoided." - Kaplan & Sadock's Comprehensive Textbook of Psychiatry
Today, formal NPT testing is rarely ordered. A careful history asking about morning erections, masturbation erections, and situational variability typically provides enough information. - StatPearls

Important Nuances

1. It Is Rarely Black and White

ED often cannot be fully dichotomized into pure psychogenic and pure organic categories. More commonly it is mixed. For example:
  • A man with mild vascular disease may initially have partial ED → develops performance anxiety → the psychogenic layer amplifies the organic problem
  • Some diabetics with established neuropathy still have a significant psychogenic component - Campbell Walsh Wein Urology; Kaplan & Sadock

2. Situational Pattern Matters Beyond Masturbation

Situational ED includes:
  • Erections with one partner but not another
  • Erections with visual stimulation but not with a specific partner
  • Erections early in a relationship but lost after conflict or intimacy problems
  • Erections at home but not in unfamiliar situations
All of these point psychogenic. - Campbell Walsh Wein Urology

3. Excessive Masturbation and Psychogenic ED

A 2026 study (PMID 41593504) found an association between frequent masturbation history and anxiety/depression in men with psychogenic ED, suggesting that conditioned hyperstimulation (e.g., high-speed internet pornography) may raise the arousal threshold needed for real-life intercourse - a phenomenon sometimes discussed as "porn-induced ED." This is a developing area; evidence remains limited but clinically recognized in younger men.

4. Young Men With ED

ED in men under 40 is predominantly psychogenic. A 2026 case report (PMID 41968500) highlighted "perceived erectile dysfunction" in a young male with multiple associated psychological factors - where the man believed he had ED largely due to anxiety-driven misinterpretation of normal performance variation.

Clinical Approach When Masturbation Erections Are Normal

If a man reports normal erections during masturbation (and/or on waking), the clinical approach shifts:
  1. Minimal/no organic workup needed - basic labs (testosterone, glucose, lipids) are still reasonable but no need for vascular imaging or NPT testing
  2. Psychosexual history - explore anxiety, depression, relationship issues, pornography use, sexual trauma, partner dynamics
  3. First-line treatment: Psychosexual counseling or sex therapy (cognitive-behavioral approaches), rather than jumping straight to PDE5 inhibitors
  4. PDE5 inhibitors can still help - by breaking the anxiety-failure-anxiety cycle and restoring confidence, even in pure psychogenic ED; they are often used as a short-term "circuit breaker" while addressing the underlying psychology
  5. Treat comorbid depression/anxiety - SSRIs can help mood but may worsen ED (a therapeutic dilemma); bupropion is a useful alternative as it has lower sexual side effects
Summary: Normal erections during masturbation = the erectile mechanism is physically intact = think psychogenic ED. The problem is in the head (literally), not in the penis. This distinction guides workup, avoids unnecessary invasive testing, and directs treatment toward psychological intervention rather than purely pharmacological approaches.
This is a shared conversation. Sign in to Orris to start your own chat.